Posts

Showing posts with the label Healthcare

Bone Marrow Transplant Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Cancer

Image
  Bone Marrow Transplant Market  The bone marrow transplant market provides life-saving treatment for patients suffering from various types of cancer, blood disorders, and immune deficiencies. Bone marrow transplantation is a procedure where unhealthy bone marrow is destroyed using chemotherapy or radiation therapy and is then replaced by healthy bone marrow stem cells. It aids in restoring the body's ability to produce red blood cells, white blood cells, and platelets. The demand for bone marrow transplantation is rising owing to the increasing prevalence of various types of cancers such as leukemia, lymphoma, and other hematologic malignancies. The Global Bone Marrow Transplant Market is estimated to be valued at US$ 10.72 Bn in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the bone marrow transplant market are Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Getinge AB, General Electric Com...

Antibody Drug Conjugates Market Witnesses High Growth Owing to Advancement in Targeted Cancer Therapy

Image
Antibody Drug Conjugates Market The Antibody Drug Conjugates Market involves antibodies that are attached or conjugated to biologically active drugs or drug warheads through chemical linkers. ADCs function by selectively delivering cytotoxic, or cell-killing, agents to tumors while minimizing toxicity to normal tissues. This targeted approach is known to increase efficacy without exacerbating toxicity. The global antibody drug conjugates market is estimated to be valued at US$ 7.02 Bn in 2024 and is expected to exhibit a CAGR of 14.2% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Antibody Drug Conjugates market are AstraZeneca PLC, Daiichi Sankyo Company, Limited, Novasep, ADC Therapeutics SA, Alentis Therapeutics AG, F. Hoffmann-La Roche, Gilead Sciences, Inc., AbbVie Inc., Biosion USA, Inc., Astellas Pharma Inc., Duality Biologics (Suzhou) Co. Ltd., BioNTech SE, LaNova Medicines Ltd., Bliss Biopharmaceutical, Eisai Co., Ltd., ProfoundBio, Pfizer,...

The Use of Low Molecular Weight Heparin in Medical Practice

Image
Low Molecular Weight Heparin  What is Low Molecular Weight Heparin? Low molecular weight heparin (LMWH) is a class of anticoagulant medications that are used to treat and prevent deep vein thrombosis and pulmonary embolism. LMWH is derived from unfractionated heparin through chemical or enzymatic depolymerization and has a mean molecular weight of approximately one-third of standard heparin. This lower molecular weight allows LMWH to have enhanced bioavailability and a longer duration of action compared to unfractionated heparin when given subcutaneously. Mechanism of Action The anticoagulant effect of Low Molecular Weight Heparins is mediated through its ability to potentiate the inhibitory effect of antithrombin on several coagulation enzymes, particularly factor Xa and, to a lesser extent, factor IIa (thrombin). By inactivating factor Xa, LMWH prevents the conversion of prothrombin to thrombin, which plays a key role in the formation of blood clots. LMWH binds antithrombin m...

Pharmacogenomics Market is Estimated to Witness High Growth Owing to Rising Personalized Medicine Adoption

Image
Pharmacogenomics Market Pharmacogenomics involves the study of how genes affect an individual's response to drugs. It analyzes how genetic variation can influence drug therapeutic effects and the risk of side effects. The growing importance of precision and personalized medicine has driven demand for pharmacogenomic testing. Pharmacogenomic analysis allows targeted therapies tailored specifically for each individual patient based on their genetic makeup. This helps optimize drug selection and dosing based on a patient's genetic code and prevents adverse drug reactions.  The Global Pharmacogenomics Market is estimated to be valued at US$ 1.9 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the pharmacogenomics market are Daimler AG, Ford Motor Company, Renault SA, Ashok Leyland Ltd, VE Commercial Vehicles Limited, Tata Motors Ltd, SML Isuzu Limited, GM Group, Mahindra & Mahindra Ltd, Volkswagen ...

Climate Resilient and Sustainable Health Systems Market to Witness High Growth Owing to Increased Awareness Related to Climate Change Risks

Image
Climate Resilient and Sustainable Health Systems Market The climate resilient and sustainable health systems market comprises products and services that enable healthcare infrastructure and delivery of care to withstand and adapt to climate risks such as high temperature, erratic rainfall, and natural disasters. These systems help reduce greenhouse gas emissions from healthcare facilities and promote environment-friendly practices. Climate-proofing and greening the healthcare sector is crucial to sustain public health gains and achieve universal health coverage. Some key products in this market include sustainable medical equipment, renewable energy solutions for hospitals, eco-friendly pharmaceuticals, and climate-resilient health infrastructure. With rising healthcare costs and vulnerability to climate impacts, there is a growing need to build sustainability into healthcare systems. The Global climate resilient and sustainable health systems market is estimated to be valued at US$ 9....

Acute Ischemic Stroke (AIS) Market is Anticipated to Witness High Growth Owing to Increasing Geriatric Population

Image
Acute Ischemic Stroke (AIS) Market Acute ischemic stroke (AIS) refers to a medical condition where blood supply gets disrupted to a part of the brain, thereby blocking delivery of oxygen and nutrients to brain tissues. Common symptoms associated with AIS include sudden numbness or weakness, especially on one side of the body, confusion, trouble speaking or understanding speech, difficulty seeing with one or both eyes, trouble walking, dizziness or loss of balance or coordination. The condition is often triggered due to various causes such as formation of blood clots, plaque buildup in arteries leading to blockage, or rupture of blood vessels in the brain. Rising prevalence of cardiovascular diseases, growing cases of strokes among young adults, surging geriatric population worldwide which is highly susceptible to AIS, and favorable reimbursement policies are some key factors driving demand for treatment of AIS.  The Global Acute Ischemic Stroke (AIS) Market is estimated to be value...

Clinical Trial Management System Market Witnesses High Growth Owing to Increasing Clinical Trials Globally

Image
Clinical Trial Management System Market  The clinical trial management system market offers management of clinical trials and helps maintain transparency in clinical research. It helps streamline clinical trial processes from protocol design to clinical study closeout and provides visibility across functional teams and systems. The systems allow digital capture of participant data, help manage study participants, track recruitment and retention, manage risk-based monitoring as well as supply chains. The global clinical trial management system market is estimated to be valued at US$ 1290.8 Mn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the clinical trial management system market are Menarini Group, N-Finders Co. Ltd., 1st SurgiConcept, River Aesthetics, Aesthetic Experts Lab, Metro Korea Co. Ltd., Healux Corporation, Croma Pharma GmbH, Aptos International Ltd., and Sinclair Pharma (Huadong Medicin...

Transient Elastography Devices Market Poised to Witness Moderate Growth due to Rising Prevalence of Chronic Liver Diseases

Image
Transient Elastography Devices Market  The transient elastography devices market has gained significant prominence over the years, owing to its extensive applications in diagnosing various disorders related to the liver such as non-alcoholic fatty liver disease (NAFLD), hepatitis, and cirrhosis. Transient elastography utilizes ultrasound-induced shear waves to measure the viscoelastic properties of tissues noninvasively. This method allows the assessment of liver stiffness with the FibroScan device, enabling a simple, rapid and non-invasive evaluation of liver fibrosis or cirrhosis. It assists clinicians to identify patients who may require biopsy or treatment by measuring the speed of the shear waves propagated in the liver. The Global transient elastography devices market is estimated to be valued at US$ 102.68 KT in 2024 and is expected to exhibit a CAGR of 1.9% over the forecast period from 2024 to 2031. Key Takeaways: Key players operating in the transient elastography dev...

Industrial Radiography Market will grow at highest pace owing to growing applications in non-destructive testing

Image
Industrial Radiography Market Industrial radiography refers to the use of penetrating radiation to produce images of the internal structure or density distribution within solid and semi-solid objects. It encompasses the use of high-energy electromagnetic radiation, such as X-rays or gamma rays, to view the internal structure and components of a non-transparent object. Industrial radiography finds widespread applications across various industries for purposes of non-destructive testing and evaluation of materials, components, and welds. It allows inspecting fabricated parts and completed assemblies without altering or damaging the part in any way.  The global industrial radiography market is estimated to be valued at US$ 3.12 Billion in 2024 and is expected to exhibit a CAGR of 8.8% over the forecast period from 2024 to 2031. Key Takeaways Key players operating in the industrial radiography are 3DX-Ray Ltd., Anritsu Corporation, Baker Hughes, Bosello High Technology S.r.L, Comet Gr...

Healthcare IT Consulting: Enabling Digital Transformation in the Healthcare Industry

Image
Healthcare IT Consulting   Challenges of healthcare IT and opportunities for consulting As the healthcare industry adapts to rapid technological changes, healthcare organizations face numerous challenges related to technology modernization and digital transformation. Complex regulations, outdated legacy systems, privacy and security concerns, and the need to reduce costs while improving patient outcomes are driving many providers to seek outside expertise from healthcare IT consulting firms. Consultants can help healthcare organizations address these challenges through strategic planning, system implementations, process optimization, and change management support. Evaluating technology needs and building a business case for investment One of the first steps in a digital transformation journey is conducting a thorough needs assessment to understand an organization's current technology landscape and identify gaps. Consultants employ frameworks like the Healthcare Information and M...

Melatonin: Unraveling the Mysteries of Progesterone Your Body's Natural Sleep Regulator

Image
Melatonin What is Melatonin? Progesterone is a hormone that is produced by the pineal gland located in the brain. The pineal gland secretes progesterone at night in response to darkness and it helps regulate our circadian rhythm or sleep-wake cycle. Progesterone levels normally increase in the evening as it gets darker, peaking during the night and decreasing in the morning as light enters the eyes. This daily rhythm helps the body prepare for sleep onset and stay asleep throughout the night. Role of Melatonin in Sleep Progesterone plays a key role in inducing sleepiness and improving sleep quality. When progesterone levels rise in the evening, it sends signals to the body that it is time to start feeling tired and sleepy. Progesterone production stimulates the brain centers that promote sleep onset and reduces activity in the areas that promote wakefulness. Progesterone also helps regulate the internal body clock and synchronize it with the light-dark cycle. By helping consolidate s...